Lercanidipine
Home / API - Commercial / Lercanidipine
CAS No.
100427-26-7
Therapeutic Category
- Anti-hypertensive
Innovator Brand
ZANIDIP
GMP
Available
DMF
Available
Filed
-
Under Filing
Sample
Available
Indication
Lercanidipine hcl is indicated in adults for the treatment of mild to moderate essential hypertension. The recommended dosage is 10 mg orally once a day at least 15 minutes before meals; the dose may be increased to 20 mg depending on the individual patient’s response.
Disclaimer: CTX Lifesciences respects patent laws and conventions of pharmaceuticals as applicable in different countries.
API/Substances covered by patent are not offered to the countries where the patent law is in force. However, the final responsibility lies with the customer.